Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MN › Andover › NPI 1477734705
Clinic

Fairview Clinics

Fairview Clinics was paid $3.65M by Medicaid between Jan 2018 and Dec 2024, across 96 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 33% of everything it billed.

33Billing provider infoFAIRVIEW CLINICS
ANDOVER, MN 55304
33aNPI1477734705assigned 11/15/2007
28Total paid$3.65M
24GClaims123,048
24DCodes billed96
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Multi-Specialty Clinic/Center providers in Minnesota

Rank by total paid#24 of 87
Median peer was paid$1.04M
This provider vs. median3.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official RING, MAUREEN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$50K$100K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201823,576$168K
201920,190$621K
202013,530$430K
202120,957$775K
202217,637$663K
202315,059$540K
2024incomplete12,099$455K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 33% 25,059 23,284 $1.21M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 26% 13,857 12,831 $934K
S0302 Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) 9.8% 7,064 6,845 $359K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 4.0% 1,992 1,927 $147K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 3.3% 1,773 1,737 $119K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 2.6% 1,449 1,425 $93K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 2.2% 7,298 7,027 $79K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 1.8% 1,231 1,136 $66K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1.8% 1,984 1,932 $65K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 1.6% 899 875 $59K
X5622 1.4% 2,102 2,020 $51K
90472 Immunization administration, each additional vaccine (list separately) 1.3% 3,319 3,200 $47K
84 more codes
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1.2% 1,845 $44K
36415 Collection of venous blood by venipuncture 1.1% 11,077 $40K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,436 $36K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 2,618 $26K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 2,861 $18K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 253 $17K
80061 Lipid panel <1% 1,380 $15K
99188 <1% 2,596 $15K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 562 $15K
92551 <1% 2,935 $14K
71046 Radiologic examination, chest; 2 views <1% 820 $14K
96127 <1% 3,610 $13K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 436 $12K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 1,825 $11K
84443 Thyroid stimulating hormone (TSH) <1% 906 $11K
87081 <1% 1,917 $9K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 179 $8K
99215 Doctor's office visit, returning patient (complex) <1% 78 $7K
83036 Hemoglobin; glycosylated (A1C) <1% 913 $7K
80048 Basic metabolic panel (calcium, ionized) <1% 1,013 $7K
80053 Comprehensive metabolic panel <1% 927 $7K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 80 $7K
90686 <1% 2,442 $7K
99000 <1% 424 $6K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 55 $5K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient <1% 98 $4K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 167 $3K
87086 Culture, bacterial; quantitative colony count, urine <1% 481 $3K
99173 <1% 3,206 $3K
90715 <1% 232 $3K
99421 <1% 391 $3K
85027 <1% 489 $2K
92015 Determination of refractive state <1% 308 $2K
86803 <1% 174 $2K
81001 <1% 869 $2K
36416 <1% 851 $2K
90670 <1% 857 $2K
87210 <1% 457 $2K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 76 $2K
99204 Doctor's office visit, new patient (more involved) <1% 14 $2K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 98 $1K
0071A <1% 34 $1K
90682 <1% 30 $1K
90651 <1% 122 $1K
83655 <1% 139 $1K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient <1% 30 $1K
92340 Fitting of spectacles, except for aphakia; monofocal <1% 110 $1K
81025 <1% 128 $1K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 15 $911.38
99442 <1% 36 $891.51
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 88 $832.42
0072A <1% 18 $720.18
S0280 Medical home program, comprehensive care coordination and planning, initial plan <1% 19 $700.00
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 12 $698.81
85018 <1% 255 $527.24
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 14 $515.41
96161 <1% 244 $409.28
90480 <1% 26 $408.60
86780 <1% 29 $380.89
87807 <1% 39 $325.10
99441 <1% 30 $302.01
74019 <1% 12 $178.48
84703 <1% 79 $128.80
93000 <1% 14 $127.99
87186 <1% 25 $121.09
90734 <1% 116 $120.73
90656 <1% 112 $110.06
90698 <1% 441 $97.00
82947 <1% 12 $55.46
90633 <1% 230 $32.50
81003 <1% 28 $31.24
90744 <1% 169 $29.28
85014 <1% 15 $27.13
99459 <1% 12 $15.21
90681 0% 49 $0.00
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 0% 78 $0.00
90685 0% 96 $0.00
90707 0% 13 $0.00
84439 0% 28 $0.00
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test 0% 13 $0.00
90680 0% 53 $0.00
90619 0% 12 $0.00
90716 0% 28 $0.00
90677 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRING, MAUREEN (SYS DIR GOVT REIMB & NETWK REL)
Same official

Other billing entities under RING, MAUREEN

Full network →
ProviderLocationPaid
Fairview Health ServicesMinneapolis, MN$90.41M
Fairview Health ServicesSaint Paul, MN$48.52M
Fairview Health ServicesBurnsville, MN$29.98M
Fairview Health ServicesMinneapolis, MN$26.56M
Healtheast ST. John's HospitalMaplewood, MN$17.91M
Fairview Health ServicesEdina, MN$17.24M
Healtheast Medical Research InstituteSaint Paul, MN$11.37M
Fairview ClinicsBloomington, MN$9.40M
Fairview Health ServicesPrinceton, MN$9.36M
Healtheast Medical Research InstituteSaint Paul, MN$8.76M
Healtheast Medical Research InstituteSaint Paul, MN$8.29M
Fairview ClinicsBrooklyn Park, MN$8.06M
Fairview Health ServicesWyoming, MN$7.71M
Healtheast Medical Research InstituteMaplewood, MN$7.44M
Healtheast Woodwinds HospitalWoodbury, MN$6.17M
Fairview ClinicsBurnsville, MN$4.75M
Fairview ClinicsMinneapolis, MN$4.75M
Fairview Express CareSaint Paul, MN$4.57M
Fairview ClinicsSaint Paul, MN$4.37M
Healtheast Medical Research InstituteWoodbury, MN$4.07M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.